KAHF Biotech is on its way to open a new avenue for treatment and prevention of cancer metastasis. The main focus of KAHF Biotech is on cancer cell plasticity and metastasis.

We Will Bring Preventive and Therapeutic Approaches Against Cancer Metastasis

Cellular Plasticity

Cellular plasticity is characterized by the ability of cells to convert between different (intermediate) cellular states by inducing epithelial-to-mesenchymal transition (EMT), as well as mesenchymal-to-epithelial transition (MET)

Orthotopic Model

We are able to develop Pancreatic Ductal Adenocarcinoma (PDAC) orthotopic models where genetically engineered PDAC cell lines or patient-derived cells implement into the pancreas or animal.

Cancer Metastasis

Metastatic tumor cells acquire certain features, allowing them to survive and grow out within a distant hostile microenvironment. All these characteristics can be controlled by unlocking cellular plasticity.

KAHF Biotech

KAHF Biotech is on its way

Collaboration

We are eager to collaborate with Angel Investors and Venture Capital.

Team Work

OUR MISSION

KAHF Biotech is in preliminary stage of development. The mission of company is to open a new avenue for treatment and prevention of cancer metastasis.

Muhammad Sadeqi Nezhad is a cancer researcher at University of Rochester Medical Center, New York, USA. Currently, he is working with a great team on development of cancer therapeutics for pancreatic cancer patients at Wilmot Cancer Institute. One of his research desires is to develop novel therapeutic approaches for cancer patients with metastasis.

Besides the cancer research, He is working at Office of Technology Transfer at University of Rochester (URVenture). He as an entrepreneur, is seeking to find pains in his research area to design and develop a novel therapeutic and preventive technologies with great unmet market need.

The company’s focus is on Cancer Plasticity and Metastasis.

Mission Statement

Our mission is to seek and set the foundation to become the industry leader in metastatic cancer drugs development and to help cancer patients with metastatic tumor cells.

Vision

To address the current challenges of metastatic cancer treatment by creating impactful therapeutic approaches that will be effective, affordable, and accessible to far more cancer patients around the world.

 

OUR SKILLS
Development
Design
Marketing
Consulting
Screenshot
Screenshot

Muhammad Sadeqi Nezhad, Founder of KAHF Biotech

KAHF Biotech

0
HOURS OF WORK
0
FINISHED WORKS
0
CLIENTS
0
SOCIAL FOLLOWERS

Email address:

Work 1: muhammad_sadeqinezhad@kahfbiotech.com

Work 2: labmsn9@gmail.com